The possibility that the FDA has continued to exte
Post# of 148191
(Total Views: 604)
Posted On: 07/20/2023 2:35:39 PM
Quote:
The possibility that the FDA has continued to extend this hold for several months beyond when CYDY has submitted all of the requested safety related data simply in order to satisfy the idle curiosity of FDA staffers regarding a benefit risk analysis of LL for HIV and the content of a draft HIV protocol that may or may not ever be formally submitted, is deeply concerning.
Exactly. The safety of LL is well-established. The hold is bullshit and if mgmt are just playing nice and going along with the hoop-jumping *beyond safety*, it's infuriating.
(6)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼